Australia markets closed

C4 Therapeutics, Inc. (CCCC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.16-0.64 (-9.41%)
At close: 04:00PM EDT
6.26 +0.10 (+1.61%)
After hours: 06:51PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts7799
Avg. Estimate-0.39-0.37-1.62-1.73
Low estimate-0.46-0.48-2.52-3.01
High estimate-0.28-0.25-1.08-0.81
Year ago EPS-0.73-0.55-2.65-1.62
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts7687
Avg. Estimate4.81M7.07M24.09M21.24M
Low estimateN/AN/A3MN/A
High estimate10M17.4M46M50M
Year ago sales2.66M5.46M20.76M24.09M
Sales growth (year/est)80.60%29.50%16.10%-11.80%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.69-0.66-0.68-0.35
Actual EPS-0.73-0.55-0.7-0.41
Difference-0.040.11-0.02-0.06
Surprise %-5.80%16.70%-2.90%-17.10%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.39-0.37-1.62-1.73
7 days ago-0.5-0.49-1.85-1.92
30 days ago-0.5-0.49-1.85-1.92
60 days ago-0.5-0.49-1.85-1.92
90 days ago-0.56-0.49-2.36-2.76
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days5554
Up last 30 days5554
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/A1N/A
Growth estimatesCCCCIndustrySector(s)S&P 500
Current qtr.46.60%N/AN/AN/A
Next qtr.32.70%N/AN/AN/A
Current year38.90%N/AN/AN/A
Next year-6.80%N/AN/AN/A
Next 5 years (per annum)22.30%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A